Systemic Treatment of Early Breast Cancer by Hormonal, Cytotoxic, or Immune Therapy:133 Randomised Trials involoving 31 000 Recurrences and 24 000 Deaths Among 75 000 Women (Summary)

Richárd Pető

doi:10.1007/978-3-642-84745-5_21

Keywords

MedicineHormonal therapyTamoxifenBreast cancerClinical trialOncologyInternal medicineAdjuvantGynecologyCancerChemotherapyRandomized controlled trialImmunotherapy

Affiliated Institutions

Kantonsspital St. Gallen CH

Related Publications

Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer. An Overview of 61 Randomised Trials Among 28,896 Women

R Peto

We sought information worldwide on mortality according to assigned treatment in all randomised trials that began before 1985 of adjuvant tamoxifen or cytotoxic therapy for early...

1989 Hormone Research 40 citations

Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer

Early Breast Cancer Trialists' Collaborative Group

We sought information worldwide on mortality according to assigned treatment in all randomized trials that began before 1985 of adjuvant tamoxifen or cytotoxic therapy for early...

1988 New England Journal of Medicine 933 citations

Randomized Trial of Two Versus Five Years of Adjuvant Tamoxifen for Postmenopausal Early Stage Breast Cancer

Five years of adjuvant tamoxifen is more beneficial than 2 years in the treatment of postmenopausal women with estrogen receptor-positive, early stage, invasive breast cancer.

1996 JNCI Journal of the National Cancer I... 263 citations

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women

EARLYBREASTCANCERTRIALISTSCOL

1992 The Lancet 366 citations

Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.

Bernard Fisher , Carol Redmond , S Legault-Poisson +7 more

The National Surgical Adjuvant Breast and Bowel Project (NSABP) conducted a randomized clinical trial to determine whether tamoxifen (TAM) plus chemotherapy is more effective th...

1990 Journal of Clinical Oncology 294 citations

Publication Info

Year: 1993
Type: book-chapter
Pages: 153-157
Citations: 965
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Systemic Treatment of Early Breast Cancer by Hormonal, Cytotoxic, or Immune Therapy:133 Randomised Trials involoving 31 000 Recurrences and 24 000 Deaths Among 75 000 Women (Summary)

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

965

OpenAlex

Cite This

APA Style

                            
                                    Richárd Pető
                                
                            (1993). 
                            Systemic Treatment of Early Breast Cancer by Hormonal, Cytotoxic, or Immune Therapy:133 Randomised Trials involoving 31 000 Recurrences and 24 000 Deaths Among 75 000 Women (Summary). 
                            Recent results in cancer research/Recent Results in Cancer Research
                            
                            , 153-157.
                            https://doi.org/10.1007/978-3-642-84745-5_21

Identifiers

DOI: 10.1007/978-3-642-84745-5_21